BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16149025)

  • 1. Use of the platelet reactivity index by Grotemeyer, platelet function analyzer, and retention test Homburg to monitor therapy with antiplatelet drugs.
    Koscielny J; Aslan T; Meyer O; Kiesewetter H; Jung F; Mrowietz C; Latza R
    Semin Thromb Hemost; 2005; 31(4):464-9. PubMed ID: 16149025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet reactivity index by Grotemeyer].
    Koscielny J; Meyer O; Kiesewetter H; Jung F; Latza R
    Hamostaseologie; 2004 Aug; 24(3):207-10. PubMed ID: 15314707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring acetylsalicylic acid effects with the platelet function analyzer PFA-100.
    Feuring M; Schultz A; Losel R; Wehling M
    Semin Thromb Hemost; 2005; 31(4):411-5. PubMed ID: 16149018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis?
    von Lewinski F; Riggert J; Paulus W
    J Stroke Cerebrovasc Dis; 2009; 18(2):111-5. PubMed ID: 19251186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the retention test Homburg in evaluating platelet hyperactivity and in monitoring therapy with antiplatelet drugs.
    Krischek B; Brannath W; Klinkhardt U; Graff J; Wieding U; Nemeh A; Heinrich W; Schenk J; Wenzel T; Wenzel E
    Semin Thromb Hemost; 2005; 31(4):458-63. PubMed ID: 16149024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to aspirin and clopidogrel monitored with different platelet function methods.
    Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E
    Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet function tests and flow cytometry to monitor antiplatelet therapy.
    Matzdorff A
    Semin Thromb Hemost; 2005; 31(4):393-9. PubMed ID: 16149015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can platelet function tests predict the clinical efficacy of aspirin?
    Haubelt H; Anders C; Hellstern P
    Semin Thromb Hemost; 2005; 31(4):404-10. PubMed ID: 16149017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of systemic inflammation on the interpretation of response to antiplatelet therapy, monitored by PFA-100.
    Ziegler S; Alt E; Brunner M; Speiser W; Minar E
    Semin Thromb Hemost; 2005; 31(4):416-9. PubMed ID: 16149019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modification of the Wu and Hoak method for the determination of platelet aggregates and platelet adhesion.
    Bowry SK; Prentice CR; Courtney JM
    Thromb Haemost; 1985 Jun; 53(3):381-5. PubMed ID: 3931286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke.
    Karepov V; Tolpina G; Kuliczkowski W; Serebruany V
    Cerebrovasc Dis; 2008; 26(3):272-6. PubMed ID: 18648200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for aspirin resistance in stable coronary artery patients by three different tests.
    Chakroun T; Addad F; Abderazek F; Ben-Farhat M; Hamdi S; Gamra H; Hassine M; Ben-Hamda K; Samama MM; Elalamy I
    Thromb Res; 2007; 121(3):413-8. PubMed ID: 17553552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring antiplatelet drug effects in the laboratory.
    Harrison P; Frelinger AL; Furman MI; Michelson AD
    Thromb Res; 2007; 120(3):323-36. PubMed ID: 17239428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
    Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
    Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of effects of aspirin on platelet function in healthy volunteers: an analysis using the PFA-100.
    Konrad CJ; Schuepfer GK; Gerber H; Rukwied R; Schmelz M; Schley M
    J Clin Anesth; 2006 Feb; 18(1):12-7. PubMed ID: 16517326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adhesion, spreading, and aggregation of platelets in flowing blood and the reliability of the retention test Homburg.
    Krischek B; Morgenstern E; Mestres P; Klinkhardt U; Brannath W; Wieding U; Nemeh A; Heinrich W; Schenk J; Wenzel T; Wenzel E
    Semin Thromb Hemost; 2005; 31(4):449-57. PubMed ID: 16149023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Retention Index Test Homburg (RTH-II): Response to clopidogrel and comparison with aggregometry and CD62P-expression.
    Klinkhardt U; Wenzel E; Harder S
    Platelets; 2006 Feb; 17(1):42-8. PubMed ID: 16308186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A; Cerletti C; de Gaetano G
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
    Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
    Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.